Praxis Precision Medicines, Inc.

PRAX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Market Cap$903,016$797,384$1,537,675
- Cash$149,527$157,415$165,567$215,372
+ Debt$0$755$1,066$1,369
Enterprise Value$746,356$632,883$1,323,672
Revenue$0$0$0$7,463
% Growth-100%
Gross Profit-$65,797-$63,006-$60,806-$48,825
% Margin-654.2%
EBITDA-$73,915-$76,021-$74,681-$63,909
% Margin-856.3%
Net Income-$73,934-$71,127-$69,296-$58,679
% Margin-786.3%
EPS Diluted-3.36-3.31-3.29-2.94
% Growth-1.5%-0.6%-11.9%
Operating Cash Flow-$64,738-$54,676-$52,707-$56,122
Capital Expenditures$0-$120$0$0
Free Cash Flow-$64,738-$54,796-$52,707-$56,122
Praxis Precision Medicines, Inc. (PRAX) Financial Statements & Key Stats | AlphaPilot